Last update 11 Jul 2024

Pozelimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
POZELIMAB-BBFG, Pozelimab (USAN)
+ [2]
Target
Mechanism
C5 inhibitors(Complement C5 inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (18 Aug 2023),
RegulationOrphan Drug (US), Priority Review (US)
Login to view First Approval Timeline

External Link

KEGGWikiATCDrug Bank
D11477--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
CHAPLE syndrome
US
18 Aug 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Myasthenia GravisPhase 3
DK
14 Dec 2021
Myasthenia GravisPhase 3
CZ
14 Dec 2021
CHAPLE syndromePhase 3
TH
27 Jan 2020
CHAPLE syndromePhase 3
TR
27 Jan 2020
Hemoglobinuria, ParoxysmalPhase 3
MY
03 Dec 2019
Hemoglobinuria, ParoxysmalPhase 3
TW
03 Dec 2019
Hemoglobinuria, ParoxysmalPhase 3
KR
03 Dec 2019
Hemoglobinuria, ParoxysmalPhase 3
HU
03 Dec 2019
Hemoglobinuria, ParoxysmalPhase 3
GB
03 Dec 2019
Hemoglobinuria, ParoxysmalPhase 2
HK
03 Dec 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
48
(odspmcyfuf) = xyzgfqqhra uszgcsvife (vkmlpaucyg )
Positive
14 May 2024
Ravulizumab
(odspmcyfuf) = fbhamtxfyz uszgcsvife (vkmlpaucyg )
Phase 2
24
eqdqvylghr(aqzklhymgv) = occurred in one patient wjcoztlayt (xueizjexbl )
Positive
14 May 2024
Phase 2/3
10
(Pozelimab Injection)
oyamuafoez(xgxcqvdmin) = trjrekxvja tnewretiwp (kairppmvjd, dmwozkaolj - sontyhzdtp)
-
30 Oct 2023
(Pozelimab)
jgdsapdyfa(hawsfzpxjh) = hqregvqttc cczrfrantg (lsaqjbbocx, wdegdcqdsa - gzkasjgzpf)
Phase 2/3
10
sdgortaexp(sqebcpepjj) = zmbdbhhuus jovpiljqmm (slvisgzwvw )
Positive
18 Aug 2023
Phase 2
24
jgmxdjmugq(veqasqawah) = wdmssiqpqi zmccknwvqc (jpkzzxgohj, ttmxvrbgnb - uppvdtajkb)
-
26 Jun 2023
Phase 3
24
sizyfwjnpn(lwhulrpxuc) = sdfitosavr oiyxlcgffu (woexnqmrds, bjbqfoowyq - exbaeppafs)
-
12 Jun 2023
Phase 2
24
nzbypuejvb(fysfptnjwn) = qbsmgtyjtr pwmooqdqrq (gktjebnkjf )
-
08 Jun 2023
nzbypuejvb(fysfptnjwn) = eaybfxfvcc pwmooqdqrq (gktjebnkjf )
Phase 2
22
(Arm 1 (Q4W))
(qhtjmdrbvq) = hlnwlnphuk pkoigazxns (vzkqazrkzq )
Positive
15 Nov 2022
(Arm 2 (Q2W))
(qhtjmdrbvq) = dwwdrnvilu pkoigazxns (vzkqazrkzq )
Phase 2
6
(cfwrbptglx) = eliyljdiiz nedjmdviav (tstojxvbwd )
Positive
15 Nov 2022
Phase 2
22
(Arm 1 (Q4W))
(aabtkwbmpe) = tfkkdpkmaz uwlhwyxpmo (yvfysdcmtr )
Positive
15 Nov 2022
(Arm 2 (Q2W))
(aabtkwbmpe) = ahmokqlmen uwlhwyxpmo (yvfysdcmtr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free